Our team of Clinical Nurse Liaisons has specialization in medication administration practices and are available for in-person and virtual support. We want clinicians to be comfortable and confident using Simplist.
Optilytics analyzes existing data from automated dispensing cabinets (ADCs) and provides a succinct road map for reorganization. Utilizing a few standard reports from your ADC, Optilytics from Fresenius Kabi can make the storage of Simplist simple, time-effective, and efficient.
All Optilytics Simplist reports are complimentary
Removes manual analysis of finding space for Simplist
Provides directions to efficiently implement Simplist
AJHP Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems*
The Third Consensus Conference on the Safety of Intravenous Drug Delivery Systems was convened to evaluate the benefits and risks of available systems and assess ongoing threats to the safety of intravenous drug delivery.*
These guidelines are based on a patient-centric, team-based model of care created by leaders within the American Society of Anesthesiologists to help meet the demands of a rapidly approaching health care paradigm.
These care pathways form an integrated continuum, as the patient moves from home through the pre-hospital/pre-admission, preoperative, intraoperative, and postoperative phases of surgery and home again.
APSF Multimodal Analgesia and Alternatives to Opioids for Postoperative Analgesia
This article describes the rationale for use of multimodal analgesia and discusses non-opioid medications that can be used as part of a multimodal approach to postoperative pain relief.
ASHP Guidelines: Minimum Standard for Pharmacies in Hospitals
These minimum standard guidelines are intended to serve as a basic guide for the provision of pharmacy services in hospitals. These guidelines outline a minimum level of services that most hospital pharmacy departments should consistently provide.
ASHP Guidelines on Preventing Diversion of Controlled Substances
The purpose of these guidelines is to provide guidance to health systems on planning for and implementing best practices when establishing a comprehensive Controlled Substance Diversion Prevention Program.
A Continuous Observation Workflow Time Study to Assess Intravenous Push Waste*
This article discusses the financially significant costs associated with wasting both the product and the valuable time of a skilled workforce and ways to reduce this financial burden on our health-systems.*
CDC’s Position — Protect Patients Against Preventable Harm from Improper Use of Single-dose / Single-use Vials
In an effort to ensure clinicians are clear about CDC guidelines, the Agency is restating its position on the use of single-dose/single-use vials and also seeks to dispel inaccuracies being disseminated to healthcare providers.
ISMP Safe Practice Guidelines for Adult IV Push Medications*
The ISMP Guidelines for Safe Practice of Adult IV Push Medications were developed to help healthcare facilities standardize the safe administration of parenteral IV push medications and prevent unsafe practices and at-risk behaviors associated with IV push administration of adult medications.*
Joint Commission Pain Management Standards for Accredited Organizations
The Joint Commission’s requirements outline a multi-level approach to pain management to help frontline staff and clinicians deliver safe, individualized pain care.
The tool is composed of four modules designed to help hospitals in assessing the challenges and barriers and prioritizing and developing corrective action plans to improve the safety of injectable medications.
Risk of Patient Harm Related to Unnecessary Dilution of Ready-to-Administer Prefilled Syringes: A Literature Review*
The purpose of this article is to review the existing literature and to assess the incidence and nature of errors related to the unnecessary dilution of RTA intravenous (IV) push medications in the inpatient clinical setting*
Notice: You have clicked on a link which leaves Fresenius Kabi’s
website, and you will be redirected to a third-party website.
Fresenius Kabi makes no representations nor has any supervision or
control over the quality, content, reliability or security of the
third-party website, nor shall Fresenius Kabi be liable for its
use.